Integra LifeSciences Reports First Quarter 2024 Financial Results
May 06, 2024 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Ilkka-konsernin osavuosikatsaus 1.1.-31.3.2024
May 06, 2024 06:00 ET
|
Ilkka Oyj
Ilkka Oyj Osavuosikatsaus 6.5.2024, klo 13.00ILKKA-KONSERNIN OSAVUOSIKATSAUS 1.1.-31.3.2024 TAMMI-MAALISKUU 2024- Liikevaihto 13 451 tuhatta euroa (14 187 tuhatta euroa)- Oikaistu oman...
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
May 06, 2024 06:00 ET
|
ADC Therapeutics SA
Initial data from 15 patients with relapsed/refractory (r/r) marginal zone lymphoma (MZL) show 13 patients achieved a complete response and one patient achieved a partial response with ZYNLONTA® All...
Veterinary Scales Market to Reach $0.52 Billion by 2033; Rapidly Growing Pet Population to Propel Growth
May 06, 2024 06:00 ET
|
The Brainy Insights
Newark, May 06, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 0.25 Billion Veterinary Scales Market will reach USD 0.52 Billion by 2033. Technological penetration in the global...
USI Insurance Services Acquires Hignojos Insurance Agency
May 06, 2024 06:00 ET
|
USI Insurance Services
VALHALLA, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- USI Insurance Services (“USI”), a world leader in risk management, employee benefit and retirement plan consulting, today announced the acquisition...
Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
May 06, 2024 06:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health...
AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
May 06, 2024 06:00 ET
|
Asclepix
The DISCOVER Phase 1/2a trial is an open-label, single ascending dose, 9-month study that will evaluate the safety and bioactivity of AXT107 (gersizangitide) injected suprachoroidally in patients with...
Craft.co Announces Five Year, $28 Million Contract with Secretary of the Air Force for Supplier Risk and Intelligence Technology
May 06, 2024 06:00 ET
|
Craft
SAN FRANCISCO, May 06, 2024 (GLOBE NEWSWIRE) -- Craft.co (www.craft.co), the supply chain resilience company, today announced a $28 million, five-year agreement with the Secretary of the Air Force...
Pulsar Helium Announces Spring Road Restrictions End at Topaz Project
May 06, 2024 06:00 ET
|
Pulsar Helium
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Pulsar Helium Inc. (TSXV:PLSR & OTCQB:PSRHF) (“Pulsar” or the “Company”) is pleased to announce that the Minnesota Department of...
Fejl i indre værdi i Investeringsforeningen Sparinvest
May 06, 2024 05:47 ET
|
Investeringsforeningen Sparinvest
Det skal oplyses, at der den 3. maj i perioden 09:45 til 10:55, er sket en fejl i beregningen af indre værdi for nedenstående afdeling. Indre værdi for nedenstående afdeling har i perioden været...